AI Governance Starts at Home
HHS’s new artificial intelligence strategy tests management-based regulation.
Who Is Really in Charge of Drug Scheduling?
Scholar argues that HHS and the DEA should balance each other’s federal drug scheduling authority.
Adding Autism Claims to the VICP Would Likely Destroy It
The costs of covering serious autism cases under the National Vaccine Injury Compensation Program (VICP) could undermine childhood vaccine production.
The Growing Pains of the No Surprises Act
Scholars reflect on the continuing impact of the No Surprises Act.
Expert Officers Under Political Supervision
The Supreme Court validates political control over public health decisions.
The Price of Preserving Preventive Services Coverage
The Supreme Court preserves preventive services coverage but emboldens the HHS Secretary.
How We Subsidize Care for Low-Income People
A Supreme Court decision reveals flaws in how we pay safety-net hospitals—and why reform is overdue.
Making Drugs Affordable Through Personal Importation
Personal importation is the fastest route to “most-favored-nation” drug pricing.
Tackling America’s High Drug Prices
Scholars discuss policy approaches to lowering the price of prescription drugs.
What You Do Not Know Can Hurt You and Others
Federal agencies under President Trump will harm public health by hiding information from the public.
Regulating Health Care Plan Fiduciaries
Scholars argue that the Department of Labor should exercise its overlooked authority to regulate health care plan fiduciaries.
Correcting the Common Sense of “Biological Sex”
The Trump Administration’s definition of biological sex does not accurately reflect modern science.